Prediction of irinotecan pharmacokinetics by use of cytochrome P450 3A4 phenotyping probes.
Mathijssen RH; de Jong FA; van Schaik RH; Lepper ER; Friberg LE; Rietveld T; de Bruijn P; Graveland WJ; Figg WD; Verweij J; Sparreboom A; Journal Of The National Cancer Institute, 2004, vol. 96, issue 21, p 1585, ISSN 14602105. ISBN 14602105.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef